269 related articles for article (PubMed ID: 34758431)
1. Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting.
Argento E; Socias ME; Hayashi K; Choi J; Mackay L; Christie D; Milloy MJ; DeBeck K
Int J Drug Policy; 2022 Feb; 100():103518. PubMed ID: 34758431
[TBL] [Abstract][Full Text] [Related]
2. The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women.
Argento E; Braschel M; Walsh Z; Socias ME; Shannon K
J Psychopharmacol; 2018 Dec; 32(12):1385-1391. PubMed ID: 30255717
[TBL] [Abstract][Full Text] [Related]
3. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis.
Lake S; Walsh Z; Kerr T; Cooper ZD; Buxton J; Wood E; Ware MA; Milloy MJ
PLoS Med; 2019 Nov; 16(11):e1002967. PubMed ID: 31743343
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada.
El-Akkad SE; Nolan S; Hayashi K; Dong H; Milloy MJ; Debeck K; Ti L
J Addict Dis; 2023; 41(3):204-212. PubMed ID: 35727118
[TBL] [Abstract][Full Text] [Related]
5. The association of psychedelic use and opioid use disorders among illicit users in the United States.
Pisano VD; Putnam NP; Kramer HM; Franciotti KJ; Halpern JH; Holden SC
J Psychopharmacol; 2017 May; 31(5):606-613. PubMed ID: 28196428
[TBL] [Abstract][Full Text] [Related]
6. High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.
Socías ME; Wood E; Lake S; Nolan S; Fairbairn N; Hayashi K; Shulha HP; Liu S; Kerr T; Milloy MJ
Addiction; 2018 Dec; 113(12):2250-2258. PubMed ID: 30238568
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of intentional substance use to reduce illicit opioid use in a Canadian setting.
Klimas J; Mok WY; Lake S; Eugenia Socías M; DeBeck K; Hayashi K; Wood E; Milloy MJ
J Subst Use; 2022; 27(3):277-282. PubMed ID: 35685454
[TBL] [Abstract][Full Text] [Related]
8. Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada.
Beaulieu T; Hayashi K; Nosova E; Milloy MJ; DeBeck K; Wood E; Kerr T; Ti L
Am J Drug Alcohol Abuse; 2020 Jul; 46(4):506-511. PubMed ID: 31983241
[TBL] [Abstract][Full Text] [Related]
9. Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting.
Argento E; Strathdee SA; Tupper K; Braschel M; Wood E; Shannon K
BMJ Open; 2017 Sep; 7(9):e016025. PubMed ID: 28939573
[TBL] [Abstract][Full Text] [Related]
10. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
[TBL] [Abstract][Full Text] [Related]
11. Non-medical prescription opioid use and in-hospital illicit drug use among people who use drugs.
Parmar GS; Hayashi K; Nolan S; Milloy MJ; DeBeck K; Shulha HP; Kerr T; Ti L
Drug Alcohol Rev; 2021 Sep; 40(6):959-963. PubMed ID: 33543535
[TBL] [Abstract][Full Text] [Related]
12. Increasing availability of illicit and prescription opioids among people who inject drugs in a Canadian setting, 2010-2014.
Ho J; DeBeck K; Milloy MJ; Dong H; Wood E; Kerr T; Hayashi K
Am J Drug Alcohol Abuse; 2018; 44(3):368-377. PubMed ID: 29048952
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with changes in illicit opioid use during the COVID-19 pandemic among incarcerated people who use drugs in Quebec, Canada.
Park H; Linthwaite B; Dussault C; Halavrezos A; Chalifoux S; Sherman J; Del Balso L; Buxton JA; Cox J; Kronfli N
Int J Prison Health; 2022 Dec; 19(3):464-73. PubMed ID: 36519779
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada.
Glynos NG; Kruger DJ; Kolbman N; Boehnke K; Lucas P
J Psychoactive Drugs; 2023; 55(5):660-671. PubMed ID: 37516904
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and correlates of selling illicit cannabis among people who use drugs in Vancouver, Canada: A ten-year prospective cohort study.
Reddon H; Fast D; DeBeck K; Werb D; Hayashi K; Wood E; Milloy MJ
Int J Drug Policy; 2019 Jul; 69():16-23. PubMed ID: 31015080
[TBL] [Abstract][Full Text] [Related]
16. Increasing preference for fentanyl among a cohort of people who use opioids in Vancouver, Canada, 2017-2018.
Ickowicz S; Kerr T; Grant C; Milloy MJ; Wood E; Hayashi K
Subst Abus; 2022; 43(1):458-464. PubMed ID: 34283705
[No Abstract] [Full Text] [Related]
17. Long term pre-treatment opioid use trajectories in relation to opioid agonist therapy outcomes among people who use drugs in a Canadian setting.
Dong H; Hayashi K; Fairbairn N; Milloy MJ; DeBeck K; Wood E; Kerr T
Addict Behav; 2021 Jan; 112():106655. PubMed ID: 32977270
[TBL] [Abstract][Full Text] [Related]
18. Increasing diversion of methadone in Vancouver, Canada, 2005-2015.
Reddon H; Ho J; DeBeck K; Milloy MJ; Liu Y; Dong H; Ahamad K; Wood E; Kerr T; Hayashi K
J Subst Abuse Treat; 2018 Feb; 85():10-16. PubMed ID: 29291766
[TBL] [Abstract][Full Text] [Related]
19. Prescription opioid use and non-fatal overdose in a cohort of injection drug users.
Lake S; Wood E; Buxton J; Dong H; Montaner J; Kerr T
Am J Drug Alcohol Abuse; 2015 May; 41(3):257-63. PubMed ID: 25699628
[TBL] [Abstract][Full Text] [Related]
20. Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid agonist therapy during a community-wide overdose crisis.
Socías ME; Choi J; Lake S; Wood E; Valleriani J; Hayashi K; Kerr T; Milloy MJ
Drug Alcohol Depend; 2021 Feb; 219():108420. PubMed ID: 33342591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
